Acarbose (Alvogen, Inc.)
Welcome to the PulseAid listing for the Acarbose drug offered from Alvogen, Inc.. This alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen, Inc. |
| NON-PROPRIETARY NAME: | acarbose |
| SUBSTANCE NAME: | ACARBOSE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2008-01-30 |
| END MARKETING DATE: | 0000-00-00 |
Acarbose HUMAN PRESCRIPTION DRUG Details:
| Item Description | Acarbose from Alvogen, Inc. |
| LABELER NAME: | Alvogen, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2008-01-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-340_6b3a1576-6f9a-4dd3-b5f7-794c81ce335a |
| PRODUCT NDC: | 47781-340 |
| APPLICATION NUMBER: | NDA020482 |
Other ACARBOSE Pharmaceutical Manufacturers / Labelers:
